A co-evolutionary perspective on humans and Mycobacterium tuberculosis in the era of systems biology
eLife · 07.01.2026 · 14
DOI: 10.7554/elife.108175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift eLife, online erschienen am 07.01.2026. Verfasst von Michaela T Reichmann und 8 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Biomedical Research Centre, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, Unite…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Systems Biology, Tuberculosis, Host-Pathogen Interactions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Rosetrees Trust, Academy of Medical Sciences.
Abstract (Originalsprache)
Tuberculosis is once again the most fatal global infectious disease and has killed many more humans than any other pathogen. Despite the identification of Mycobacterium tuberculosis (Mtb) over 140 years ago, we have yet to control the epidemic. A central issue is the complexity of the host–pathogen interaction, with multiple underlying pathways leading to tuberculosis disease. This intricate relationship stems from the prolonged co-evolution of the pathogen with humans, resulting in diverse immunological processes leading to tuberculosis disease. Conversely, Mtb exposure may give a survival advantage through innate immune training, thereby providing selective pressure over millennia. Emerging methodologies, such as single-cell and spatial transcriptomics, offer a golden opportunity to understand the immunology unpinning this host–pathogen interaction at unprecedented resolution. However, these analyses will be fundamentally flawed if they do not consider the intricacies of human Mtb infection. Here, we propose that attempts to find single immunological mechanisms leading to tuberculosis are hindering progress, and we must embrace the complexity of multiple paths to disease to allow the systems biology era to deliver transformative solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NIHR Biomedical Research Centre, Clinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
- Institute for Life Sciences, Southampton, United Kingdom.
- Africa Health Research Institute, Durban, South Africa.
- College of Health Sciences, School of Laboratory Medicine and Medical Sciences, University of KwaZulu Natal, Durban, South Africa.
- Department of Infection and Immunity, University College London, London, United Kingdom.
ORCID-Profile: Michaela T Reichmann, Liku B Tezera, Salah Mansour, Diana J Garay-Baquero, Paul T Elkington
Förderung
- Medical Research Council
- Rosetrees Trust
- Academy of Medical Sciences
- Wellcome Trust
- Gates Foundation
Zitieren
APA
Reichmann, M. T., Tezera, L. B., Denney, L., Schiff, H., Vallejo, A., Mansour, S., Leslie, A., Garay-Baquero, D. J., & Elkington, P. T. (2026). A co-evolutionary perspective on humans and Mycobacterium tuberculosis in the era of systems biology. eLife, 14. https://doi.org/10.7554/elife.108175
Vancouver
Reichmann MT, Tezera LB, Denney L, Schiff H, Vallejo A, Mansour S, et al. A co-evolutionary perspective on humans and Mycobacterium tuberculosis in the era of systems biology. eLife. 2026;14. doi:10.7554/elife.108175
BibTeX
@article{Reichmann2026,
author = {Reichmann, Michaela T and Tezera, Liku B and Denney, Laura and Schiff, Hannah and Vallejo, Andres and Mansour, Salah and Leslie, Alasdair and Garay-Baquero, Diana J and Elkington, Paul T},
title = {A co-evolutionary perspective on humans and Mycobacterium tuberculosis in the era of systems biology},
journal = {eLife},
year = {2026},
volume = {14},
doi = {10.7554/elife.108175}
}
EUVIMED